Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Jan 16, 2019
EVP & Chief Financial Officer
EVP & Chief Financial Officer Open market or private sale of non-derivative or derivative security 3,207 $10.44
Jan 16, 2019
EVP, COO & CCO
EVP, COO & CCO Open market or private sale of non-derivative or derivative security 10,499 $10.44
Jan 16, 2019
EVP, COO & CCO
EVP, COO & CCO Other acquisition or disposition -- --
Jan 16, 2019
Director, CEO & President
Director, CEO & President Open market or private sale of non-derivative or derivative security 5,091 $10.44
Jan 09, 2019
EVP & Chief Financial Officer
EVP & Chief Financial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,326 --
Jan 09, 2019
EVP & Chief Financial Officer
EVP & Chief Financial Officer Other acquisition or disposition -- --
Jan 09, 2019
EVP & Chief Financial Officer
EVP & Chief Financial Officer Open market or private sale of non-derivative or derivative security 33,692 $10.87
Jan 09, 2019
Director, CEO & President
Director, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 133,434 --
Jan 09, 2019
Director, CEO & President
Director, CEO & President Open market or private sale of non-derivative or derivative security 36,311 $10.87
Jan 07, 2019
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 7,250 --
Jan 07, 2019
Director
Director Open market or private sale of non-derivative or derivative security 7,250 $10.00
Jan 07, 2019
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 7,250 $3.92
Dec 06, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 7,250 $3.92
Dec 06, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 7,250 --
Dec 06, 2018
Director
Director Open market or private sale of non-derivative or derivative security 7,250 $12.60
Nov 30, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 3,333 --
Nov 30, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 6,667 --
Nov 30, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 14,507 --
Nov 30, 2018
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 6,667 --
Nov 09, 2018
Director
Director Initial Statement of Beneficial Ownership of Securities -- --
Nov 08, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 7,250 $3.92
Nov 08, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 7,250 --
Nov 08, 2018
Director
Director Open market or private sale of non-derivative or derivative security 7,250 $13.07
Oct 09, 2018
Director
Director Open market or private sale of non-derivative or derivative security 10,000 $15.34
Aug 08, 2018
SVP and Chief Legal Officer
SVP and Chief Legal Officer Other acquisition or disposition -- --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright West LLC. Minimum 15 minutes delayed.